HUP9802679A2 - Multidrog rezisztencia hatással rendelkező tetralinszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények - Google Patents
Multidrog rezisztencia hatással rendelkező tetralinszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítményekInfo
- Publication number
- HUP9802679A2 HUP9802679A2 HU9802679A HUP9802679A HUP9802679A2 HU P9802679 A2 HUP9802679 A2 HU P9802679A2 HU 9802679 A HU9802679 A HU 9802679A HU P9802679 A HUP9802679 A HU P9802679A HU P9802679 A2 HUP9802679 A2 HU P9802679A2
- Authority
- HU
- Hungary
- Prior art keywords
- powder
- ring
- alkyl
- general formula
- tube
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical class C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 title 1
- 239000000843 powder Substances 0.000 abstract 9
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 150000002466 imines Chemical group 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 230000035945 sensitivity Effects 0.000 abstract 1
- 125000003107 substituted aryl group Chemical group 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
- C07C45/46—Friedel-Crafts reactions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
- C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
- C07C49/755—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups a keto group being part of a condensed ring system with two or three rings, at least one ring being a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
A találmány tárgyát a sejtek bizőnyős gyógyszerekkel szembenmegnyilvánűló érzékenységét megtartó, főkőzó vagy helyreállító (I)általánős képletű új vegyületek -, ahől A, B és C hidrőgén- vagy halőgénatőm, alkil- vagy alkőxicsőpőrt, (CH2)n-Arvagy Y(CH2)n-Ar általánős képletű csőpőrt, amelyekben Y őxigénatőm,kénatőm vagy iminőcsőpőrt, n értéke 0-4, és Ar adőtt esetbenszűbsztitűált aril- vagy heterőarilcsőpőrt; D hidrőgénatőm vagy (CH2)m-E általánős képletű csőpőrt, amelyben E adőttesetben szűbsztitűált aminőcsőpőrt vagy nitrőgéntartalmúheterőciklűsős csőpőrt, és m értéke 1-3; X őxigénatőm vagy adőtt esetben alkil- vagy aralkil-szűbsztitűáltiminőcsőpőrt; J és K egymástól függetlenül alkil- vagy Ar-alkil-csőpőrt, vagy együttesen5- vagy 6-tagú, adőtt esetben benzőlgyűrűvel kőndenzált gyűrűt képez;és M alkilcsőpőrt vagy az Ar jelentéseként megadőtt - és az előállításűkra szőlgáló eljárás, valamint a vegyületekettartalmazó gyógyszerkészítmények és alkalmazásűk képezik. ŕ
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/444,567 US5726184A (en) | 1995-05-19 | 1995-05-19 | Tetralin compounds with improved MDR activity |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP9802679A2 true HUP9802679A2 (hu) | 1999-03-29 |
HUP9802679A3 HUP9802679A3 (en) | 2000-03-28 |
Family
ID=23765456
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9802679A HUP9802679A3 (en) | 1995-05-19 | 1996-05-16 | Tetralin derivatives with mdr activity, process for producing them and pharmaceutical compositions containing them |
Country Status (22)
Country | Link |
---|---|
US (1) | US5726184A (hu) |
EP (1) | EP0839143B1 (hu) |
JP (1) | JPH11505255A (hu) |
KR (1) | KR19990014848A (hu) |
CN (1) | CN1184475A (hu) |
AT (1) | ATE221881T1 (hu) |
AU (1) | AU705167B2 (hu) |
BR (1) | BR9608789A (hu) |
CA (1) | CA2219752A1 (hu) |
CZ (1) | CZ364197A3 (hu) |
DE (1) | DE69622871T2 (hu) |
DK (1) | DK0839143T3 (hu) |
ES (1) | ES2179945T3 (hu) |
HU (1) | HUP9802679A3 (hu) |
IL (1) | IL118269A0 (hu) |
NO (1) | NO975198L (hu) |
NZ (1) | NZ308789A (hu) |
PL (1) | PL323490A1 (hu) |
PT (1) | PT839143E (hu) |
SK (1) | SK155497A3 (hu) |
WO (1) | WO1996036630A1 (hu) |
ZA (1) | ZA963959B (hu) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5798355A (en) * | 1995-06-07 | 1998-08-25 | Gpi Nil Holdings, Inc. | Inhibitors of rotamase enzyme activity |
US5859031A (en) | 1995-06-07 | 1999-01-12 | Gpi Nil Holdings, Inc. | Small molecule inhibitors of rotamase enzyme activity |
US5696135A (en) | 1995-06-07 | 1997-12-09 | Gpi Nil Holdings, Inc. | Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth |
US5811434A (en) * | 1996-11-13 | 1998-09-22 | Vertex Pharmacueticals Incorporated | Methods and compositions for stimulating neurite growth |
US5958949A (en) | 1996-12-31 | 1999-09-28 | Gpi Nil Holdings Inc. | N-linked ureas and carbamates of piperidyl thioesters |
US5935989A (en) | 1996-12-31 | 1999-08-10 | Gpi Nil Holdings Inc. | N-linked ureas and carbamates of heterocyclic thioesters |
US5846979A (en) | 1997-02-28 | 1998-12-08 | Gpi Nil Holdings, Inc. | N-oxides of heterocyclic esters, amides, thioesters, and ketones |
US5945441A (en) | 1997-06-04 | 1999-08-31 | Gpi Nil Holdings, Inc. | Pyrrolidine carboxylate hair revitalizing agents |
FR2781218B1 (fr) * | 1998-07-15 | 2001-09-07 | Lafon Labor | Compositions pharmaceutiques comprenant des 2-quinolones |
US6337340B1 (en) | 1998-08-14 | 2002-01-08 | Gpi Nil Holdings, Inc. | Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders |
US6218423B1 (en) | 1998-08-14 | 2001-04-17 | Gpi Nil Holdings, Inc. | Pyrrolidine derivatives for vision and memory disorders |
US6395758B1 (en) | 1998-08-14 | 2002-05-28 | Gpi Nil Holdings, Inc. | Small molecule carbamates or ureas for vision and memory disorders |
US6462072B1 (en) | 1998-09-21 | 2002-10-08 | Gpi Nil Holdings, Inc. | Cyclic ester or amide derivatives |
US6300341B1 (en) | 1998-09-30 | 2001-10-09 | The Procter & Gamble Co. | 2-substituted heterocyclic sulfonamides |
US6307049B1 (en) | 1998-09-30 | 2001-10-23 | The Procter & Gamble Co. | Heterocyclic 2-substituted ketoamides |
AU5606400A (en) | 1999-07-09 | 2001-01-30 | Ortho-Mcneil Pharmaceutical, Inc. | Neurotrophic tetrahydroisoquinolines and tetrahydrothienopyridines, and related compositions and methods |
FR2797444B1 (fr) | 1999-08-13 | 2003-02-07 | Lafon Labor | Compositions pharmaceutiques comprenant des 4-quinolones |
EA200300473A1 (ru) * | 2000-10-16 | 2003-08-28 | Неофарм, Инк. | Терапевтическая композиция на основе митоксантрона (варианты) и липидный препарат, способ его получения и способ лечения заболевания млекопитающего с его использованием |
US6693099B2 (en) | 2000-10-17 | 2004-02-17 | The Procter & Gamble Company | Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance |
US6376514B1 (en) | 2000-10-17 | 2002-04-23 | The Procter & Gamble Co. | Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof |
MXPA03011095A (es) * | 2001-05-29 | 2005-04-28 | Guilford Pharm Inc | Metodo para tratar una lesion nerviosa causada por cirugia. |
EP1451856A2 (en) * | 2001-11-07 | 2004-09-01 | Pharmacia Corporation | Methods of promoting uptake and nuclear accumulation of polyamides in eukaryotic cells |
WO2005007162A1 (en) * | 2003-07-10 | 2005-01-27 | Vertex Pharmaceuticals Incorporated | Compounds augmenting the activity of antibacterial agents |
US20080221163A1 (en) * | 2005-01-18 | 2008-09-11 | Jeffrey Alan Dodge | Selective Estrogen Receptor Modulators |
EP2475365A1 (en) | 2009-09-11 | 2012-07-18 | Vertex Pharmaceuticals Incorporated | Compositions of n-benzyl-3-(4-chlorophenyl)-2-[methyl-[2-oxo-2-(3,4,5-trimethoxyphenyl) acetyl]amino]-n-[3-(4-pyri(dyl)-1-[2-[4-pyridyl)ethyl]propyl]propanamide and uses thereof |
CN103130631A (zh) * | 2011-11-29 | 2013-06-05 | 中国人民解放军第二军医大学 | 1-取代苯亚甲基-2-萘酮类衍生物及制备方法和用途 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5192773A (en) * | 1990-07-02 | 1993-03-09 | Vertex Pharmaceuticals, Inc. | Immunosuppressive compounds |
NZ314207A (en) * | 1992-09-28 | 2000-12-22 | Vertex Pharma | 1-(2-Oxoacetyl)-piperidine-2-carboxylic acid derivatives as multi drug resistant cancer cell sensitizers |
US5387685A (en) * | 1993-07-16 | 1995-02-07 | American Cyanamid Co | MDR reversal agents |
-
1995
- 1995-05-19 US US08/444,567 patent/US5726184A/en not_active Expired - Lifetime
-
1996
- 1996-05-15 IL IL11826996A patent/IL118269A0/xx unknown
- 1996-05-16 JP JP8535063A patent/JPH11505255A/ja not_active Ceased
- 1996-05-16 HU HU9802679A patent/HUP9802679A3/hu unknown
- 1996-05-16 DE DE69622871T patent/DE69622871T2/de not_active Expired - Fee Related
- 1996-05-16 CA CA002219752A patent/CA2219752A1/en not_active Abandoned
- 1996-05-16 CN CN96194028A patent/CN1184475A/zh active Pending
- 1996-05-16 DK DK96920255T patent/DK0839143T3/da active
- 1996-05-16 NZ NZ308789A patent/NZ308789A/xx not_active IP Right Cessation
- 1996-05-16 WO PCT/US1996/007094 patent/WO1996036630A1/en active IP Right Grant
- 1996-05-16 SK SK1554-97A patent/SK155497A3/sk unknown
- 1996-05-16 PL PL96323490A patent/PL323490A1/xx unknown
- 1996-05-16 CZ CZ973641A patent/CZ364197A3/cs unknown
- 1996-05-16 AT AT96920255T patent/ATE221881T1/de not_active IP Right Cessation
- 1996-05-16 AU AU58620/96A patent/AU705167B2/en not_active Ceased
- 1996-05-16 BR BR9608789A patent/BR9608789A/pt not_active Application Discontinuation
- 1996-05-16 PT PT96920255T patent/PT839143E/pt unknown
- 1996-05-16 KR KR1019970708193A patent/KR19990014848A/ko not_active Application Discontinuation
- 1996-05-16 ES ES96920255T patent/ES2179945T3/es not_active Expired - Lifetime
- 1996-05-16 EP EP96920255A patent/EP0839143B1/en not_active Expired - Lifetime
- 1996-05-17 ZA ZA963959A patent/ZA963959B/xx unknown
-
1997
- 1997-11-12 NO NO975198A patent/NO975198L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ATE221881T1 (de) | 2002-08-15 |
BR9608789A (pt) | 1999-02-17 |
EP0839143A1 (en) | 1998-05-06 |
CA2219752A1 (en) | 1996-11-21 |
NO975198L (no) | 1998-01-19 |
ES2179945T3 (es) | 2003-02-01 |
AU705167B2 (en) | 1999-05-20 |
NO975198D0 (no) | 1997-11-12 |
HUP9802679A3 (en) | 2000-03-28 |
JPH11505255A (ja) | 1999-05-18 |
EP0839143B1 (en) | 2002-08-07 |
IL118269A0 (en) | 1996-09-12 |
CN1184475A (zh) | 1998-06-10 |
ZA963959B (en) | 1996-11-25 |
AU5862096A (en) | 1996-11-29 |
WO1996036630A1 (en) | 1996-11-21 |
DE69622871T2 (de) | 2003-04-10 |
SK155497A3 (en) | 1998-04-08 |
CZ364197A3 (cs) | 1998-03-18 |
NZ308789A (en) | 1999-07-29 |
DK0839143T3 (da) | 2002-11-18 |
KR19990014848A (ko) | 1999-02-25 |
DE69622871D1 (de) | 2002-09-12 |
PT839143E (pt) | 2002-12-31 |
US5726184A (en) | 1998-03-10 |
PL323490A1 (en) | 1998-03-30 |
MX9708830A (es) | 1998-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9802679A2 (hu) | Multidrog rezisztencia hatással rendelkező tetralinszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények | |
HUP9900973A2 (hu) | Antibakteriális hatású mutilin-karbamoil-oxi-származékok, ezeket tartalmazó gyógyszerkészítmények és eljárás a vegyületek előállítására | |
HUP9900616A2 (hu) | Triciklusos vegyületek, eljárás előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
HUP9802323A2 (hu) | Pirimidinszármazékok, eljárás előállításukra és az ezeket tartalmazó gyógyászati készítmények | |
HUP0004259A2 (hu) | VLA-4 által mediált leukocita adhéziót gátló szubsztituált fenilalanin-származékok, ezeket tartalmazó gyógyászati készítmények | |
HUP0001285A2 (hu) | Proteáz inhibitor hatású pirrolidinszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények | |
HUP9902471A2 (hu) | Piperazin- és piperidinvegyületek, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények | |
HUP9902340A2 (hu) | Kondenzált piridinek és pirimidinek aril-amino-származékai, eljárás előállításukra, valamint e vegyületeket tartalmazó gyógyászati készítmények, továbbá e vegyületek alkalmazása | |
HUP9700328A2 (hu) | Heteroaril-oxazolidinonok, eljárás előállításukra, a vegyületeket tartalmazó gyógyszerkészítmények, alkalmazásuk és köztitermékeik | |
HUP0004531A2 (hu) | VLA-4 által mediált leukocita adhéziót gátló 4-aminofenilalanin-vegyületek, ezeket tartalmazó gyógyászati készítmények, valamint alkalmazásuk | |
GB1496872A (en) | Da forfarande for framstellning av karbostyrol- eller 3,4-dihydrokarbosty | |
HUP9802865A2 (hu) | N-(szubsztituált fenil-)-pirazol-származékok, előállításuk és alkalmazásuk, a vegyületeket hatóanyagként tartalmazó parazitaellenes készítmények | |
HUP9900120A2 (hu) | Benzoszulfonszármazékok, eljárás előállításukra, valamint ezeket a vegyületeket tartalmazó gyógyászati készítmény | |
HUP9901184A2 (hu) | Antibakteriális hatású benzoxazin- és pirido-oxazin-származékok, intermedierjeik, a vegyületeket tartalmazó gyógyászati készítmények, előállításuk és alkalmazásuk | |
HUP0002050A2 (hu) | Szubsztituált imidazolvegyületek, eljárás előállításukra, e vegyületeket tartalmazó gyógyászati készítmények és alkalmazásuk | |
HUP0401009A2 (hu) | 5-Hidroxitriptamin-6-ligandumokként alkalmazható 1-aril- vagy 1- alkil-szulfonilbenzazol-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
HUP9901613A2 (hu) | Szubsztituált tetraciklusos kondenzált furán-amin-származékok, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények | |
HUP9802937A2 (hu) | Benzo[g]kinolin-származékok, e vegyületeket tartalmazó gyógyászati készítmények, eljárás előállításukra és alkalmazásuk | |
FR2658823B1 (fr) | Nouveaux derives d'aminomethylpiperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent . | |
TR200103349T2 (tr) | Purin türevleri, hazırlama usulü ve bunları içeren ispençiyari bileşimleri. | |
SE7501365L (hu) | ||
HUP0003624A2 (hu) | 1,2,3,4-Tetrahidro-benzofuro[3,2-c]piridin-származékok, az ezeket tartalmazó gyógyszerkészítmények és eljárás előállításukra | |
HUP9701660A2 (hu) | 10,13,15-trioxa-triciklo[9.2.1.1. 9.6]pentadekanon-származékok, eljárás ezek előállítására, és az e vegyületeket tartalmazó gyógyászati készítmények | |
HUP9802407A1 (hu) | Eljárás kamptotecinszármazékok előállítására, valamint a közbenső termékként szolgáló vegyületek | |
HUP9701921A2 (hu) | Heterociklusos amino-metil-vegyületek, eljárás ezek előállítására és ezeket tartalmazó gyógyászati készítmények |